Difference between revisions of "Megestrol (Megace)"
Jump to navigation
Jump to search
m |
m (→Also known as) |
||
| (13 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
==Diseases for which it is used== | ==Diseases for which it is used== | ||
| − | *[[ | + | *[[Endometrial cancer]] |
| − | [[ | + | ==Diseases for which it was used== |
| − | [[ | + | *[[Breast cancer - historical|Breast cancer]] |
| + | *[[Renal cell carcinoma - historical|Renal cell carcinoma]] | ||
| − | + | ==History of changes in EMA indication== | |
| + | *1971-08-18: EURD | ||
| + | ==Also known as== | ||
| + | *'''Code name:''' SC-10363 | ||
| + | *'''Generic name:''' megestrol acetate | ||
| + | *'''Brand name:''' Maygace, Megace, Megestat, Megestil, Niagestin, Ovaban, Pallace | ||
| − | [[Category:Drugs FDA approved in 1971]] | + | [[Category:Drugs]] |
| + | [[Category:Oral medications]] | ||
| + | |||
| + | [[Category:Progestins]] | ||
| + | [[Category:Appetite stimulants]] | ||
| + | |||
| + | [[Category:Endometrial cancer medications]] | ||
| + | |||
| + | [[Category:Breast cancer medications (historic)]] | ||
| + | [[Category:Renal cell carcinoma medications (historic)]] | ||
| + | |||
| + | [[Category:FDA approved in 1971]] | ||
| + | [[Category:EMA approved in 1971]] | ||
| + | [[Category:Stub]] | ||
Latest revision as of 12:53, 8 September 2023
Diseases for which it is used
Diseases for which it was used
History of changes in EMA indication
- 1971-08-18: EURD
Also known as
- Code name: SC-10363
- Generic name: megestrol acetate
- Brand name: Maygace, Megace, Megestat, Megestil, Niagestin, Ovaban, Pallace